PRESENTATION

Q1 2022 — Earnings presentation

Q1 2022PDF · 24 pages2.5 MB
Mike Roman
Chairman of the Board &
Chief Executive Officer
Monish Patolawala
Executive Vice President,
Chief Financial &
Transformation Officer
2022 First Quarter Earnings
John Banovetz
Executive Vice President,
Chief Technology Officer &
Environmental Responsibility
(unaudited)
Bruce Jermeland
Senior Vice President,
Investor Relations

-- 1 of 24 --

2	2022 Q1 Earnings – April 26, 2022. All rights reserved.
Forward looking statement
This presentation contains forward-looking information about 3M's financial results and estimates and business prospects that involve substantial risks and
uncertainties. You can identify these statements by the use of words such as "anticipate," "estimate," "expect," "aim," "project," "intend," "plan," "believe," "will,"
"should," "could," "target," "forecast" and other words and terms of similar meaning in connection with any discussion of future operating or financial performance
or business plans or prospects. Among the factors that could cause actual results to differ materially are the following: (1) worldwide economic, political,
regulatory, capital markets and other external conditions and other factors beyond the Company's control, including natural and other disasters or climate change
affecting the operations of the Company or its customers and suppliers; (2) risks related to public health crises such as the global pandemic associated with the
coronavirus (COVID-19); (3) foreign currency exchange rates and fluctuations in those rates; (4) liabilities related to certain fluorochemicals, including lawsuits
concerning various PFAS-related products and chemistries, and claims and governmental regulatory proceedings and inquiries related to PFAS in a variety of
jurisdictions; (5) legal proceedings, including significant developments that could occur in the legal and regulatory proceedings described in the Company's Annual
Report on Form 10-K for the year ended Dec. 31, 2021, and any subsequent quarterly reports on Form 10-Q (the “Reports”); (6) competitive conditions and
customer preferences; (7) the timing and market acceptance of new product offerings; (8) the availability and cost of purchased components, compounds, raw
materials, labor, and energy (including oil and natural gas and their derivatives) due to shortages, increased demand and wages, logistics, manufacturing site
disruption or supply chain interruptions (including those caused by natural and other disasters and other events); (9) unanticipated problems or delays with the
phased implementation of a global enterprise resource planning (ERP) system, or security breaches and other disruptions to the Company's information technology
infrastructure; (10) the impact of acquisitions, strategic alliances, divestitures and other unusual events resulting from portfolio management actions and other
evolving business strategies, and possible organizational restructuring; (11) operational execution, including scenarios where the Company generates fewer
productivity improvements than estimated; (12) financial market risks that may affect the Company’s funding obligations under defined benefit pension and
postretirement plans; (13) the Company's credit ratings and its cost of capital; and (14) tax-related external conditions, including changes in tax rates, laws or
regulations. Changes in such assumptions or factors could produce significantly different results. A further description of these factors is located in the Reports
under "Cautionary Note Concerning Factors That May Affect Future Results" and "Risk Factors" in Part I, Items 1 and 1A (Annual Report) and in Part I, Item 2 and
Part II, Item 1A (Quarterly Reports), as updated by applicable Current Reports on Form 8-K. The information contained in this presentation is as of the date
indicated. The Company assumes no obligation to update any forward-looking statements contained in this presentation as a result of new information or future
events or developments.
This presentation refers to certain non-GAAP financial measures. Refer to 3M’s April 26, 2022, press release for descriptions of non-GAAP financial measures such
as free cash flow, adjusted free cash flow, free cash flow conversion, adjusted free cash flow conversion, net debt, adjusted EBITDA, and various measures that
adjust for the impacts of special items. These non-GAAP measures are not in accordance with, nor are they a substitute for, GAAP measures. Reconciliations of
these non-GAAP financial measures to the most directly comparable GAAP financial measures can be found in that press release.
Note on non-GAAP financial measures

-- 2 of 24 --

3	2022 Q1 Earnings – April 26, 2022. All rights reserved.
Change to non-GAAP measures - special items
• Expanding current scope of non-GAAP measure adjustments for special items to include all impacts of
accrual changes and legal fees for respirator mask, PFAS and Combat Arms matters
– Increases transparency of our financial reporting and understanding of underlying business performance
– Issued Form 8-K with updated history for the past three years reflecting this change, and updated full-year
guidance on this basis in this morning’s earnings press release
$M, except EPS
GAAP amounts comparable to non-GAAP amounts mentioned below 2021 2020 2019
Operating income $7,369 $7,161 $6,174
Operating margin 20.8% 22.3% 19.2%
EPS $10.12 $9.36 $7.72
Certain amounts adjusted for special items (non-GAAP measures)*
Previous basis for special items:
Operating income $7,369 $6,844 $6,822
Operating margin 20.8% 21.3% 21.2%
EPS $10.12 $8.85 $8.79
Updated basis for special items:
Operating income $7,832 $7,180 $6,911
Operating margin 22.2% 22.3% 21.5%
EBITDA margin 27.6% 28.2% 26.5%
EPS $10.73 $9.29 $8.90
Memo:
Impact of change on previous basis operating margin 1.4% 1.0% 0.3%
Additional net costs per share treated as special item under updated basis $0.61 $0.44 $0.11
*See 2021 Annual Report on Form 10-K and Form 8-K dated April 26, 2022 for information regarding these non-GAAP measures on the previous basis and updated basis, respectively.

-- 3 of 24 --

4	2022 Q1 Earnings – April 26, 2022. All rights reserved.
Change to non-GAAP measures - special items
Q1 2022 Q4 2021 Q1 2021
GAAP EPS $2.26 $2.31 $2.77
Special items:
Net costs for significant litigation:
Zwijndrecht-related (PFAS-related environmental commitments
as previously announced on March 30, 2022) 0.26 — —
Other significant litigation 0.13 0.14 0.18
Total 0.39 0.14 0.18
Adjusted EPS $2.65 $2.45 $2.95
Memo: Adjusted operating margin 21.4% 20.0% 24.1%
• Expanding current scope of non-GAAP measure adjustments for special items to include all impacts of
accrual changes and legal fees for respirator mask, PFAS and Combat Arms matters
– Increases transparency of our financial reporting and understanding of underlying business performance
– Issued Form 8-K with updated history for the past three years reflecting this change, and updated full-year
guidance on this basis in this morning’s earnings press release

-- 4 of 24 --

5	2022 Q1 Earnings – April 26, 2022. All rights reserved.
1
2
3
4
5
Growing faster than the markets and economies we serve
Expanding margins and EPS through operating rigor, productivity, and price
Delivering robust cash flow through supply chain recovery and improvements in working capital
Investing capital in high growth, high return portfolios that utilize our fundamental strengths
Advancing sustainability commitments to reduce GHG emissions and improve water quality
Maintaining a strong balance sheet, providing flexibility for M&A and shareholder returns	6
Delivering growth and shareholder value in 2022

-- 5 of 24 --

6
Creating value and delivering for customers
• Delivered solid growth and sequential improvement in operating margins while investing
for long-term growth in sizable, significant markets
• Focused on customers while managing supply chain, inflation, and geopolitical pressures
– Prioritizing serving our customers while managing supply chain pressures
– Driving price to offset inflationary pressures
– Managing impact of Russia/Ukraine conflict
• Optimizing portfolio to create value for customers and shareholders
– Food Safety divestiture: on track to close by end of Q3
– Acquired the technology assets of LeanTec to advance digital solutions for auto
body shop customers
• Returned $1.6B of cash to shareholders, 64 straight years of annual dividend increases
• Proactively managing litigation; filed first Combat Arms appeals
• Following through on sustainability commitments
• FY 2022 outlook: grow above macro and improve operational performance
Organic growth
+1.7%
Includes (0.5%) impact from
disposable respirator decline
Adjusted operating margin
21.4%
Adjusted earnings per share
$2.65
Q1 2022

-- 6 of 24 --

7	2022 Q1 Earnings – April 26, 2022. All rights reserved.
Executing on our environmental stewardship goals
2002 2015 2023 2025 2030 2040 2050
GHG emissions
reported by
WRI/WBCSD GHG
Protocol
69.2% Scope 1 and 2
emission reduction
(2002-2015)
39.8% water reduction
(2005-2015, indexed)
Complete installation of
water quality systems at
largest locations
20% water reduction,
indexed
125 million pounds
virgin fossil-based plastic
25% water reduction,
indexed
50% Scope 1 and 2
emission reduction
80% Scope 1 and 2
emission reduction
Carbon neutrality,
Scope 1 and 2 emissions
2021	2005 Reset GHG and water
baselines to 2019
26.1% Scope 1 and 2
emission reduction
10.7% water reduction,
indexed
Launch of Global Impact
Report – May 11, 2022
35.5% Scope 1 and 2
emission reduction
(2002-2005)
What we said: 2021 announced
$1 billion environmental investment
• 10% water reduction by 2022 moving toward
25% water reduction by 2030, indexed
• Improve water quality through installation of
purification technologies at largest water-using
locations by 2023 and fully operational by
2024
• Reduce Scope 1 and 2 emissions 50%
by 2030 and carbon neutrality in our
operations by 2050
• Reduce dependence on virgin fossil-based
plastic by 125 million pounds by 2025
Where we are: 2021 progress
• Reduced water usage nearly 11%, indexed
• Installed state-of-the-art water quality system
in Zwijndrecht; pilot work completed in Decatur,
AL; Cordova, IL; and Cottage Grove, MN
• Reduced Scope 1 & 2 emissions over 26%
• Reduced over 18 million pounds virgin-based
plastic use
Where we’re going: 2022 expectations
• Over 5% additional water reduction
• Complete installation and operation of systems to
further improve water quality in Cordova IL;
expansion of water quality capabilities in Zwijndrecht,
Cottage Grove, MN and Decatur, AL
• Bending the curve on carbon emissions, surpassing
50% renewable electricity two years ahead of plan
• Doubling the reduction of virgin-based plastic use

-- 7 of 24 --

8	2022 Q1 Earnings – April 26, 2022. All rights reserved.
Financial details of the quarter

-- 8 of 24 --

9	2022 Q1 Earnings – April 26, 2022. All rights reserved.
Q1 2022 operating margin and EPS
+9.0%
Adjusted
operating
margin
Adjusted
earnings
per share Commentary
Q1 2021 24.1% $2.95
Total organic growth/
productivity/other -0.4% $—
Disposable respirator -0.1% -$0.03 • YoY disposable respirator decline in demand
Remaining organic growth/
productivity/other -0.3% +$0.03
• Strong pricing, spending discipline and benefits from restructuring actions
• Manufacturing headwinds from global supply chain challenges, including geopolitical impacts
• Increased investments in growth, productivity and sustainability
Raw material -2.4% -$0.30 • Raw material and logistics cost inflation
FX +0.1% -$0.04 • Net of hedge impact
Other expense/income NA +$0.01 • Primarily non-operating pension expense offset by lower net interest expense
Adjusted tax rate* NA -$0.02 • Q1 2022 adjusted tax rate of 17.6% versus 16.9% in Q1 2021
Shares outstanding NA +$0.05 • Average diluted shares down 2%
Q1 2022 21.4% $2.65
* The effect of income taxes on items that had specific tax rates are reflected within their respective impacts in the table above.

-- 9 of 24 --

10	2022 Q1 Earnings – April 26, 2022. All rights reserved.
Q1 2022 cash flow and balance sheet
Adjusted free cash flow • Q1: $0.7B, down 50% YoY
Adjusted free cash flow
conversion
• Continue to expect full-year free cash flow conversion in the
range of 90% to 100%
• Q1: 47% (in-line with expectations), down 36 ppts YoY
• Q1 YoY decline due to higher cash compensation and increase in
capex for growth and sustainability investments
Capital expenditures • Q1: $424M, up 37% YoY
• Continue to expect full-year capex in the range of $1.7B to $2.0B
Net debt • Q1: $13.3B, up 2% YoY
Cash returned to
shareholders
• Q1: dividends $852M; share repurchases $773M
• Expect full-year share repurchases of ~$2B
Adjusted free cash flow
$0.7B
-50% year-on-year
Adjusted free cash flow
conversion
47%
-36 ppts year-on-year
Cash returned to
shareholders
$1.6B
+49% year-on-year

-- 10 of 24 --

11	2022 Q1 Earnings – April 26, 2022. All rights reserved.
Safety & Industrial Transportation & Electronics Health Care Consumer
Business Group performance

-- 11 of 24 --

12	2022 Q1 Earnings – April 26, 2022. All rights reserved.
Organic growth
0.5%
Includes (1.5%) impact from disposable respirator decline
Adjusted operating margin
22.9%
Q1 2022 commentary
Safety & Industrial
• Mid-single digit organic growth in industrial adhesives and
tapes, electrical markets, abrasives, and closure and masking
systems, while personal safety declined
• Disposable respirator sales declined nearly $50M, or 8%
organically YoY; reduced segment organic growth by 1.5 ppts
• Adjusted operating margins -3.5 ppts YoY; impacted by
increased raw materials/logistics costs and manufacturing
productivity headwinds; partially offset by selling price
actions, strong spending discipline and restructuring benefits
Long-term trends
Industrial activity Digitization
Sustainability Use of robotics & automation
Key investment priorities
Personal safety Connected solutions Sustainable products

-- 12 of 24 --

13	2022 Q1 Earnings – April 26, 2022. All rights reserved.
Transportation & Electronics
• Organic growth led by commercial solutions; automotive flat while
electronics and transportation safety declined
• Semiconductor supply chain challenges continue impacting global
auto builds (Q1: -5% YoY, IHS) and electronics end-markets
• Operating margins -2.0 ppts YoY; impacted by increased raw
materials/logistics costs, manufacturing productivity headwinds,
and investments in auto electrification; partially offset by selling
price actions, strong spending discipline and restructuring benefits
• Q2 forecasts: IHS auto builds up ~2% YoY and down ~(3)%
sequentially; smartphones up ~1% YoY and down ~(5)% sequentially
Q1 2022 commentary
Organic growth
-0.3%
Operating margin
21.2%
Key investment priorities
Auto electrification/mobility Semiconductor
Electronic materials Graphic and architectural films
Long-term trends
Auto electrification Fab manufacturing
Factory automation Data center solutions

-- 13 of 24 --

14	2022 Q1 Earnings – April 26, 2022. All rights reserved.
Q1 2022 commentary
• Organic growth across all divisions led by food safety, separation
and purification sciences, medical solutions and health
information systems
• COVID-19 (Omicron) continues to impact U.S. elective procedure
volumes (Q1: healthcare 85-90%; oral care 85-90% vs pre-COVID)
• Operating margins -1.4 ppts YoY; impacted by increased raw
materials/logistics costs, manufacturing productivity headwinds,
and investments; partially offset by sales growth (including selling
price actions), strong spending discipline and restructuring benefits
• U.S. healthcare elective procedure and oral care volumes expected
to improve in Q2 to 90-95% of pre-COVID levels
Health Care
Organic growth
4.7%
Operating margin
21.1%
Long-term trends
Aging population Health access
Shift to lowest-cost settings Digital & connected solutions
Key investment priorities
Wound care Healthcare IT Biopharma filtration

-- 14 of 24 --

15	2022 Q1 Earnings – April 26, 2022. All rights reserved.
Organic growth
3.4%
Operating margin
17.1%
Consumer
Q1 2022 commentary
• Organic growth across all divisions led by consumer health and
safety and continued demand for home care, stationery and
office and home improvement products
• Operating margins -3.7 ppts YoY; impacted by increased raw
materials/logistics and outsourced hardgoods manufacturing
costs, and manufacturing productivity headwinds; partially offset
by sales growth (including selling price actions), strong spending
discipline, and restructuring benefits
Key investment priorities
Home improvement Package protection & shipping
Consumer safety & well-being Appearance auto care
Long-term trends
Increased time spent at home E-commerce/digital/data analytics
Heightened focus on well-being Sustainability

-- 15 of 24 --

16	2022 Q1 Earnings – April 26, 2022. All rights reserved.
2022 outlook

-- 16 of 24 --

17	2022 Q1 Earnings – April 26, 2022. All rights reserved.
Note: Above guidance does not reflect the impact of pending divestiture of Food Safety business via Reverse Morris Trust (RMT) transaction with Neogen
Organic growth
2% to 5%
Adjusted earnings per share
$10.75 to $11.25
Free cash flow conversion
90% to 100%
2022 planning estimates –	
updated to reflect change in reporting
Current trend
Macro environment
• IPI & GDP softening to ~3%
• Monitoring Omicron subvariant impacts in China
• Geopolitical uncertainty due to Russia/Ukraine conflict
• Increasing FX volatility
End-markets
• Most end-markets are strong; however, auto OEM build (CY +4% YoY) and
smartphone (CY +2% YoY) forecasts moderating due to continued
semiconductor and supply chain challenges along with geopolitical impacts
• Industry projections for U.S. healthcare elective procedure volumes at ~95%
to 100% by year-end, impacted by COVID-19 driven staff shortages and
patient cancellations
Supply chain constraints
• Supply chain challenges worsening due to geopolitical risks
Raw materials & logistics pressure
• Raw material & logistics inflation driving incremental pressure
• Selling price expected to offset raw material & logistics inflation
Original outlook
Macro environment
• IPI & GDP of ~4%
• Uneven economic recovery due to COVID-19 variants and vaccination rates
End-markets
• End-markets expected to be strong; growth in automotive (CY+9% YoY) and
electronics (CY +4% YoY) as semiconductor chips supply progresses
• Industry projections for U.S. healthcare elective procedure volumes at ~100%
by year-end
Supply chain constraints
• Global supply chain challenges expected to remain at least through 1H 2022
Raw materials & logistics pressure
• Raw material & logistics estimated headwind of $350M to $450M YoY
• Selling price expected to offset raw material & logistics inflation

-- 17 of 24 --

18	2022 Q1 Earnings – April 26, 2022. All rights reserved.
Q&A
Mike Roman
Chairman of the Board &
Chief Executive Officer
Monish Patolawala
Executive Vice President,
Chief Financial &
Transformation Officer
John Banovetz
Executive Vice President,
Chief Technology Officer &
Environmental Responsibility
Bruce Jermeland
Senior Vice President,
Investor Relations

-- 18 of 24 --

19	2022 Q1 Earnings – April 26, 2022. All rights reserved.
Appendix

-- 19 of 24 --

20	2022 Q1 Earnings – April 26, 2022. All rights reserved.
Q1 2022 P&L
($M)
Q1
2022
Q1
2021 Change
Sales $8,829 $8,851 -0.3%
Gross profit $4,003 $4,326 -7.5%
% to sales 45.3% 48.9% -3.6 pts
SG&A $1,882 $1,808 +4.0%
% to sales 21.3% 20.5% +0.8 pts
R&D & related $480 $524 -8.4%
% to sales 5.4% 5.9% -0.5 pts
Operating income $1,641 $1,994 -17.7%
% to sales 18.6% 22.5% -3.9 pts
Net income $1,299 $1,624 -20.0%
GAAP earnings per share $2.26 $2.77 -18.4%

-- 20 of 24 --

21	2022 Q1 Earnings – April 26, 2022. All rights reserved.
Q1 2022 sales recap
Americas EMEA APAC Worldwide
Organic growth +2.5% -1.9% +2.7% +1.7%
Acquisitions/divestitures —% —% —% —%
FX —% -5.7% -2.7% -2.0%
Total growth +2.5% -7.6% —% -0.3%
U.S. Canada Mexico Brazil China/HK Japan
Organic growth +1% +22% +10% +14% -3% +3%

-- 21 of 24 --

22	2022 Q1 Earnings – April 26, 2022. All rights reserved.
Business segment information
($M) Net Sales Q1 2022 Sales Growth Adjusted Operating Income* Adjusted Operating Margin*
Business groups
Q1
2022
Q1
2021
Organic
growth FX M&A
Total
Sales
Change
Q1
2022
Q1
2021
Percent
change
Q1
2022
Q1
2021
Safety & Industrial $3,051 $3,099 0.5% -2.1% —% -1.6% $699 $817 -14.4% 22.9% 26.4%
Transportation & Electronics $2,340 $2,396 -0.3% -2.0% —% -2.3% $496 $556 -10.6% 21.2% 23.2%
Health Care $2,124 $2,069 4.7% -2.0% —% 2.7% $448 $464 -3.5% 21.1% 22.5%
Consumer $1,313 $1,289 3.4% -1.6% —% 1.8% $224 $269 -16.6% 17.1% 20.8%
Total Operating Business
Segment $1,867 $2,106
Corporate & Unallocated $1 $(2) $24 $23
Total $8,829 $8,851 1.7% -2.0% —% -0.3% $1,891 $2,129 -11.2% 21.4% 24.1%
*"Safety & Industrial", "Corporate & Unallocated", "Total Operating Business Segment" and "Total" provided on an adjusted basis
Organic growth = organic volume + price

-- 22 of 24 --

23	2022 Q1 Earnings – April 26, 2022. All rights reserved.
($M) Net Sales
Business groups Q1 2022 Q1 2021
Abrasives 329 323
Automotive Aftermarket 295 294
Closure and Masking Systems 258 243
Electrical Materials 309 301
Industrial Adhesives & Tapes 621 598
Personal Safety 1,127 1,229
Roofing Granules 112 108
Other Safety & Industrial — 3
Total Safety & Industrial Business Group 3,051 3,099
Advanced Materials 305 315
Automotive & Aerospace 460 488
Commercial Solutions 454 427
Electronics 923 951
Transportation Safety 198 215
Other Transportation & Electronics — —
Total Transportation & Electronics Business Group 2,340 2,396
($M) Net Sales
Business groups Q1 2022 Q1 2021
Food Safety 92 87
Health Information Systems 300 289
Medical Solutions 1,128 1,093
Oral Care 354 360
Separation & Purification Sciences 250 240
Other Health Care — —
Total Health Care Business Group 2,124 2,069
Consumer Health & Safety 161 144
Home Care 274 272
Home Improvement 609 604
Stationery & Office 269 268
Other Consumer — 1
Total Consumer Business Group 1,313 1,289
Corporate & Unallocated 1 (2)
Total 3M 8,829 8,851
Additional sales detail

-- 23 of 24 --



-- 24 of 24 --